|
|
||||||||
1 Section on Pulmonary and
Critical Care,
Hydrolysis of
surfactant-associated phospholipids by secretory phospholipases
A2 is an important potential
mechanism for surfactant dysfunction in inflammatory lung diseases. In
these conditions, airway secretory phospholipase A2
(sPLA2) activity is increased, but
the type of sPLA2 and its impact
on surfactant function are not well understood. We examined in
vitro the effect of multiple secretory phospholipases
A2 on surfactant, including their
ability to 1) release free fatty
acids, 2) release lysophospholipids, and 3) increase the minimum surface
tension (
min) on a pulsating bubble surfactometer. Natural porcine surfactant and Survanta were
exposed to mammalian group I (recombinant porcine pancreatic) and group
II (recombinant human) secretory phospholipases
A2. Our results demonstrate that
mammalian group I sPLA2 hydrolyzes phosphatidylcholine (PC), producing free fatty acids and
lysophosphatidylcholine, and increases
min. In contrast, mammalian
group II sPLA2 demonstrates limited hydrolysis of PC and does not increase
min. Group I and group II
secretory phospholipases A2 from
snake venom hydrolyze PC and inhibit surfactant function. In summary,
mammalian secretory phospholipases
A2 from groups I and II differ
significantly from each other and from snake venom in their ability to
hydrolyze surfactant-associated PC.
lysophospholipid; lung injury; asthma; pulsating bubble surfactometer
This article has been cited by other articles:
![]() |
G. Enhorning Surfactant in Airway Disease Chest, April 1, 2008; 133(4): 975 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Schuster, R. Alouidor, and E. S. Barquist Nonventilatory Interventions in the Acute Respiratory Distress Syndrome J Intensive Care Med, January 1, 2008; 23(1): 19 - 32. [Abstract] [PDF] |
||||
![]() |
R. D. Hite, M. C. Seeds, D. L. Bowton, B. L. Grier, A. M. Safta, R. Balkrishnan, B. M. Waite, and D. A. Bass Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L610 - L617. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Hite, M. C. Seeds, A. M. Safta, R. B. Jacinto, J. I. Gyves, D. A. Bass, and B. M. Waite Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A2-mediated surfactant dysfunction Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L618 - L624. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Bailey, E. L. Martin, L. Zhao, and R. A. W. Veldhuizen High oxygen concentrations predispose mouse lungsto the deleterious effects of high stretch ventilation J Appl Physiol, March 1, 2003; 94(3): 975 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nanjundan and F. Possmayer Pulmonary phosphatidic acid phosphatase and lipid phosphate phosphohydrolase Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L1 - L23. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Seeds, K. A. Jones, R. Duncan Hite, M. C. Willingham, H. M. Borgerink, R. D. Woodruff, D. L. Bowton, and D. A. Bass Cell-Specific Expression of Group X and Group V Secretory Phospholipases A2 in Human Lung Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., July 1, 2000; 23(1): 37 - 44. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |